Description
Mechanism of Action Study for COH29 Compare COH29 treatment in DNA-repair deficient cell line with truncated BRCA1 (HCC1937) versus phenotypically normal cell line with exogenous WT BRCA1 expression (HCC1937+BRCA1)
| Date made available | 2015 |
|---|---|
| Publisher | ArrayExpress |
Research output
- 1 Article
-
The novel ribonucleotide reductase inhibitor COH29 inhibits DNA repair in vitros
Chen, M. C., Zhou, B., Zhang, K., Yuan, Y. C., Un, F., Hu, S., Chou, C. M., Chen, C. H., Wu, J., Wang, Y., Liu, X., Smith, D. L., Li, H., Liu, Z., Warden, C. D., Su, L., Malkas, L. H., Chung, Y. M., Hu, M. C. T. & Yen, Y., Jun 1 2015, In: Molecular Pharmacology. 87, 6, p. 996-1005 10 p.Research output: Contribution to journal › Article › peer-review
Open Access25 Link opens in a new tab Citations (Scopus)
Cite this
- DataSetCite